Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Dr. Prahlad Singh es el President de Revvity Inc, se unió a la empresa desde 2016.
¿Qué tal es el rendimiento del precio de la acción RVTY?
El precio actual de RVTY es de $87.63, ha aumentado un 0.19% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Revvity Inc?
Revvity Inc pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de Revvity Inc?
La capitalización bursátil actual de Revvity Inc es $9.7B
¿Es Revvity Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 20 analistas han realizado calificaciones de análisis para Revvity Inc, incluyendo 7 fuerte compra, 10 compra, 8 mantener, 1 venta, y 7 fuerte venta